P2-06-22: PreciseBreast, an AI-enabled digital test predicting breast cancer recurrence is equivalent with Oncotype in an observational, retrospective study of patients from Baptist Health Miami Cancer Institute in partnership with COTA, Inc.
P3-03-20: A multicenter retrospective review of clinical-pathological characteristics associated with survival outcomes in a large cohort of metaplastic breast cancer patients
Outcomes among Hispanic metastatic breast cancer patients treated with alpelisib and fulvestrant: Single institution retrospective study.
Abstract 967: Real-world transcriptomic biomarkers as replacement for immunohistochemistry and FISH studies in breast cancer
Real-World Study of First-Line Treatment Patterns in HR+/HER2- Metastatic Breast Cancer (MBC) at a Tertiary Care Cancer Institute
Abstract P6-08-11: Hyperglycemia in Hispanic MBC patients treated with alpelisib: single institution retrospective study
Differential impact of cognitive computing augmented by real world evidence on novice and expert oncologists
Abstract P4-14-05: Confirmation of the TAILORx 21-gene expression trial using a real world observational database
Utilization of a Precise, Clinically Relevant, Digital Classification System to Identify Variation in Care and Costs Among Patients with Breast Cancer
Oncologists’ Perspectives on Barriers to Effective Communication about Genomic Test Results and Preferences for Communication Aides
